{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:03:59Z","timestamp":1789470239330,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1124\/mol.114.092817","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T21:53:45Z","timestamp":1401746025000},"page":"479-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["The Odd Sibling: Features of \u03b23-Adrenoceptor Pharmacology"],"prefix":"10.1016","volume":"86","author":[{"given":"Hana","family":"Cernecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.114.092817_bib1","doi-asserted-by":"crossref","unstructured":"Abrams P, Kelleher C, Staskin D, Rechberger T, Kay R, Martina R, Newgreen D, Paireddy A, van Maanen R, Ridder A (2014) Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). Eur Urol. DOI: 10.1016\/j.eururo.2014.02.012 [published ahead of print]","DOI":"10.1016\/j.juro.2013.02.2377"},{"key":"10.1124\/mol.114.092817_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(95)00802-0","article-title":"A specific \u03b2 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats","volume":"298","author":"Atef","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of \u03b2-adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","article-title":"The selectivity of \u03b2-adrenoceptor agonists at human \u03b21-, \u03b22- and \u03b23-adrenoceptors","volume":"160","author":"Baker","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/mol.114.092817_bib5","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2393-7-S1-S14","article-title":"Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?","volume":"7","author":"Bardou","year":"2007","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1124\/mol.114.092817_bib6","doi-asserted-by":"crossref","first-page":"33366","DOI":"10.1074\/jbc.271.52.33366","article-title":"Down-regulation of \u03b23 adrenoreceptor gene expression in brown fat cells is transient and recovery is dependent upon a short-lived protein factor","volume":"271","author":"Bengtsson","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.092817_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0922-4106(95)90098-5","article-title":"Distribution of \u03b2 3-adrenoceptor mRNA in human tissues","volume":"289","author":"Berkowitz","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0026-895X(25)13306-3","article-title":"Structural and conformational features determining selective signal transduction in the \u03b2 3-adrenergic receptor","volume":"44","author":"Blin","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"International union of pharmacology nomenclature of adrenoceptors","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.114.092817_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(24)34946-8","article-title":"Potent and selective human \u03b2(3)-adrenergic receptor antagonists","volume":"290","author":"Candelore","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib11","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/endo.137.6.8641219","article-title":"Pharmacological characterization of a recently described human \u03b2 3-adrenergic receptor mutant","volume":"137","author":"Candelore","year":"1996","journal-title":"Endocrinology"},{"key":"10.1124\/mol.114.092817_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3565(25)38092-4","article-title":"Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion","volume":"265","author":"Carp\u00e9n\u00e9","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00210-012-0767-6","article-title":"Specificity evaluation of antibodies against human \u03b23-adrenoceptors","volume":"385","author":"Cernecka","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/bj3030973","article-title":"\u03b2 3-adrenoceptor agonist-induced down-regulation of Gs \u03b1 and functional desensitization in a Chinese hamster ovary cell line expressing a \u03b2 3-adrenoceptor refractory to down-regulation","volume":"303","author":"Chambers","year":"1994","journal-title":"Biochem J"},{"key":"10.1124\/mol.114.092817_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/mol.114.092817_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0022-3565(25)24007-1","article-title":"Influence of cell type upon the desensitization of the \u03b2 3-adrenergic receptor","volume":"271","author":"Chaudhry","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199508103330605","article-title":"Genetic variation in the \u03b2 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity","volume":"333","author":"Cl\u00e9ment","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.114.092817_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0898-6568(96)00068-X","article-title":"Endogenous \u03b2 3- but not \u03b2 1-adrenergic receptors are resistant to agonist-mediated regulation in human SK-N-MC neurotumor cells","volume":"8","author":"Curran","year":"1996","journal-title":"Cell Signal"},{"key":"10.1124\/mol.114.092817_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2014.03.003","article-title":"The pharmacological rationale for combining muscarinic receptor antagonists and \u03b2-adrenoceptor agonists in the treatment of airway and bladder disease","volume":"16C","author":"Dale","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/mol.114.092817_bib20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.2570461","article-title":"Molecular characterization of the human \u03b2 3-adrenergic receptor","volume":"245","author":"Emorine","year":"1989","journal-title":"Science"},{"key":"10.1124\/mol.114.092817_bib21","unstructured":"Engelhardt S, Ahles A, (2014) Polymorphic variants of adrenoceptors: physiology, pharmacology and role in disease. Pharmacol Rev (in press)."},{"key":"10.1124\/mol.114.092817_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2010.11.036","article-title":"Lack of evidence that nebivolol is a \u03b2\u2083-adrenoceptor agonist","volume":"654","author":"Frazier","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00210-013-0835-6","article-title":"\u03b23-adrenoceptors: a drug target in ophthalmology?","volume":"386","author":"Gericke","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/endo.130.1.1309320","article-title":"Differential adrenergic regulation of \u03b2 1- and \u03b2 3-adrenoreceptor messenger ribonucleic acids in adipose tissues","volume":"130","author":"Granneman","year":"1992","journal-title":"Endocrinology"},{"key":"10.1124\/mol.114.092817_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00210-013-0900-1","article-title":"Pharmacological profile of the selective \u03b23-adrenoceptor agonist mirabegron in cynomolgus monkeys","volume":"386","author":"Hatanaka","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","article-title":"Comparative pharmacology of human \u03b2-adrenergic receptor subtypes\u2014characterization of stably transfected receptors in CHO cells","volume":"369","author":"Hoffmann","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)00854-8","article-title":"Agonist activity of SR59230A at atypical beta-adrenoceptors in guinea pig gastric fundus and duodenum","volume":"416","author":"Horinouchi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib28","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0703160","article-title":"\u03b2(3)-adrenoceptor regulation and relaxation responses in mouse ileum","volume":"129","author":"Hutchinson","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.104.076901","article-title":"Evidence for pleiotropic signaling at the mouse \u03b23-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]","volume":"312","author":"Hutchinson","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00210-012-0824-1","article-title":"Pharmacological profile of \u03b23-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome","volume":"386","author":"Igawa","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00210-012-0763-x","article-title":"Functional investigation of \u03b2-adrenoceptors in human isolated detrusor focusing on the novel selective \u03b23-adrenoceptor agonist KUC-7322","volume":"385","author":"Igawa","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-201X.1998.00406.x","article-title":"Possible \u03b2 3-adrenoceptor-mediated relaxation of the human detrusor","volume":"164","author":"Igawa","year":"1998","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/mol.114.092817_bib33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0026-895X(25)09002-9","article-title":"Functional properties of the rat and human \u03b2 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells","volume":"42","author":"Liggett","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib34","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1073\/pnas.90.8.3665","article-title":"Structural basis for receptor subtype-specific regulation revealed by a chimeric \u03b2 3\/\u03b2 2-adrenergic receptor","volume":"90","author":"Liggett","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.092817_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/jpet.112.191783","article-title":"Effects of ritobegron (KUC-7483), a novel selective \u03b23-adrenoceptor agonist, on bladder function in cynomolgus monkey","volume":"342","author":"Maruyama","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00210-013-0936-2","article-title":"Do \u03b2-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?","volume":"387","author":"Michel","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pharmthera.2007.12.001","article-title":"Physiological and pathological regulation of the autonomic control of urinary bladder contractility","volume":"117","author":"Michel","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.114.092817_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00210-010-0529-2","article-title":"Tissue functions mediated by \u03b2(3)-adrenoceptors-findings and challenges","volume":"382","author":"Michel","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00345-009-0416-y","article-title":"Effect of pre-contraction on \u03b2-adrenoceptor-mediated relaxation of rat urinary bladder","volume":"27","author":"Michel","year":"2009","journal-title":"World J Urol"},{"key":"10.1124\/mol.114.092817_bib40","doi-asserted-by":"crossref","unstructured":"Michel MC, Teitsma CA, Vrydag W, Bontrop R, de la Rosette JJMCH, Baas F (2008) \u03b23-Adrenergic receptor gene polymorphisms: comparison of human with chimpanzee and Rhesus macaque. FASEB J 22:1134.3.","DOI":"10.1096\/fasebj.22.1_supplement.1134.3"},{"issue":"Suppl 2","key":"10.1124\/mol.114.092817_bib41","first-page":"S88","article-title":"\u03b11-, \u03b12- and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00210-013-0891-y","article-title":"Agonist-induced desensitization of human \u03b23-adrenoceptors expressed in human embryonic kidney cells","volume":"386","author":"Michel-Reher","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00210-010-0526-5","article-title":"Pharmacological evidence for the presence of functional \u03b2(3)-adrenoceptors in rat retinal blood vessels","volume":"382","author":"Mori","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib44","doi-asserted-by":"crossref","first-page":"24053","DOI":"10.1016\/S0021-9258(18)54391-X","article-title":"An adipose tissue-specific \u03b2-adrenergic receptor. Molecular cloning and down-regulation in obesity","volume":"266","author":"Muzzin","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.092817_bib45","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1002\/j.1460-2075.1991.tb04940.x","article-title":"Molecular characterization of the mouse \u03b2 3-adrenergic receptor: relationship with the atypical receptor of adipocytes","volume":"10","author":"Nahmias","year":"1991","journal-title":"EMBO J"},{"key":"10.1124\/mol.114.092817_bib46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0026-895X(25)13419-6","article-title":"The human \u03b2 3-adrenergic receptor is resistant to short term agonist-promoted desensitization","volume":"43","author":"Nantel","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0773.1977.tb02049.x","article-title":"Characterization of the adrenergic beta-receptor in the urinary bladder of man and cat","volume":"40","author":"Nerg\u00e5rdh","year":"1977","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1124\/mol.114.092817_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00210-013-0860-5","article-title":"\u03b22-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling","volume":"386","author":"Ngala","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00210-006-0104-z","article-title":"Comparison of three radioligands for the labelling of human \u03b2-adrenoceptor subtypes","volume":"374","author":"Niclau\u00df","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2012.05.053","article-title":"A multicenter, double-blind, randomized, placebo-controlled trial of the \u03b23-adrenoceptor agonist solabegron for overactive bladder","volume":"62","author":"Ohlstein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1124\/mol.114.092817_bib51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bjp.0705065","article-title":"The preferential \u03b23-adrenoceptor agonist BRL 37344 increases force via \u03b21-\/\u03b22-adrenoceptors and induces endothelial nitric oxide synthase via \u03b23-adrenoceptors in human atrial myocardium","volume":"138","author":"Pott","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib52","first-page":"955","article-title":"The use of \u03b23-adrenergic receptor agonists in the treatment of heart failure","volume":"10","author":"Rasmussen","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/mol.114.092817_bib53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell"},{"key":"10.1124\/mol.114.092817_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1474-8673.1993.tb00270.x","article-title":"Coexistence of \u03b2 2- and \u03b2 3-adrenoceptors in plasma potassium control in conscious rabbits","volume":"13","author":"Reverte","year":"1993","journal-title":"J Auton Pharmacol"},{"key":"10.1124\/mol.114.092817_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1124\/mol.107.035337","article-title":"Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists","volume":"74","author":"Sato","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib56","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1124\/mol.108.046979","volume":"74","author":"Sato","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib57","doi-asserted-by":"crossref","first-page":"20674","DOI":"10.1074\/jbc.M111.280651","article-title":"Interaction with caveolin-1 modulates G protein coupling of mouse \u03b23-adrenoceptor","volume":"287","author":"Sato","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.092817_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004240050804","article-title":"Differential down-regulation of \u03b23-adrenergic receptor mRNA and signal transduction by cold exposure in brown adipose tissue of young and senescent rats","volume":"437","author":"Scarpace","year":"1999","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.114.092817_bib59","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/jpet.103.063735","article-title":"Signal transduction underlying carbachol-induced contraction of human urinary bladder","volume":"309","author":"Schneider","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.114.092817_bib60","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/sj.npp.1301424","article-title":"Stimulation of the \u03b23-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders","volume":"33","author":"Stemmelin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.114.092817_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1254\/jjp.88.108","article-title":"Characterization of \u03b2-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey","volume":"88","author":"Takeda","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/nau.22305","article-title":"Are polymorphisms of the \u03b2(3)-adrenoceptor gene associated with an altered bladder function?","volume":"32","author":"Teitsma","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/mol.114.092817_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0026-895X(25)13619-5","article-title":"Lack of \u03b2 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human","volume":"43","author":"Thomas","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.092817_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2013.10.039","article-title":"The new radioligand [(3)H]-L 748,337 differentially labels human and rat \u03b23-adrenoceptors","volume":"720","author":"van Wieringen","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2008.00014.x","article-title":"Do gene polymorphisms alone or in combination affect the function of human \u03b23-adrenoceptors?","volume":"156","author":"Vrydag","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.114.092817_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-006-0127-5","article-title":"Tools to study \u03b23-adrenoceptors","volume":"374","author":"Vrydag","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.114.092817_bib67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM199508103330603","article-title":"Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the \u03b2 3-adrenergic-receptor gene","volume":"333","author":"Walston","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24039932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24039932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.114.092817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:24:06Z","timestamp":1739946246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24039932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0026895X24039932"],"URL":"https:\/\/doi.org\/10.1124\/mol.114.092817","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Odd Sibling: Features of \u03b23-Adrenoceptor Pharmacology","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.114.092817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}